Anonymous
Guest
Anonymous
Guest
Now that we got the black box warning for deaths associated with the rash our sales should really pick up next year. Im so excited to be here!
Now that we got the black box warning for deaths associated with the rash our sales should really pick up next year. Im so excited to be here!
I am appauled that my rep has not informed me of such events. The company knew this was going on and let me put my patients in harms way. This is what was forwarded to me from a pharmacist.
A search of the FDA Adverse Event Reporting System (AERS) database from May 23, 2011, through June 19, 2012, identified 92 cases of DRESS and 20 cases of SJS in patients taking Incivek combination treatment. The case of a 47-year-old female who continued taking Incivek combination treatment following development of DRESS was fatal. The patient developed a rash on her lower extremities after 4 weeks of triple therapy, and she continued taking all three drugs for another 4 weeks. She was hospitalized when the rash got worse. The patient developed hypotension, fever, myalgia, and acute kidney injury. She developed ventricular fibrillation and died of cardiogenic shock.
Helloooooo people, the direction has ALWAYS been to STOP the drug if the patient's rash became severe (a step BEFORE serious). These are patients who either weren't given good direction by their provider or who chose to ignore their provider, thus leading to serious consequences.
Vertex as a company and its representatives have always been open and upfront about the rash and have tried to educate and give clear direction on when the patient with a rash can continue to stay on therapy and when therapy should be stopped. Nothing has been hidden... get over yourselves, you Merck reps.
an absolute joke it took this long for this to come out. We all have docs that have had this and we brush it under the carpet hoping no else hears of it. Vertex should be investigated
Helloooooo people, the direction has ALWAYS been to STOP the drug if the patient's rash became severe (a step BEFORE serious). These are patients who either weren't given good direction by their provider or who chose to ignore their provider, thus leading to serious consequences.
Vertex as a company and its representatives have always been open and upfront about the rash and have tried to educate and give clear direction on when the patient with a rash can continue to stay on therapy and when therapy should be stopped. Nothing has been hidden... get over yourselves, you Merck reps.
Valeant is in the derm business. Maybe they will by us since we have now moved into that space.
Helloooooo people, the direction has ALWAYS been to STOP the drug if the patient's rash became severe (a step BEFORE serious). These are patients who either weren't given good direction by their provider or who chose to ignore their provider, thus leading to serious consequences.
Vertex as a company and its representatives have always been open and upfront about the rash and have tried to educate and give clear direction on when the patient with a rash can continue to stay on therapy and when therapy should be stopped. Nothing has been hidden... get over yourselves, you Merck reps.
Looks like this is the only Vertex response on this post. I guess Merck has nothing else to do except troll this board. What a joke! The black box is very clear and the direction has always been clear. Try to make more of it Merck as you have tried with other things and you will continue to get no where. You aren't respected and I'm sure you will continue down that path.
Helloooooo people, the direction has ALWAYS been to STOP the drug if the patient's rash became severe (a step BEFORE serious). These are patients who either weren't given good direction by their provider or who chose to ignore their provider, thus leading to serious consequences.
Vertex as a company and its representatives have always been open and upfront about the rash and have tried to educate and give clear direction on when the patient with a rash can continue to stay on therapy and when therapy should be stopped. Nothing has been hidden... get over yourselves, you Merck reps.
Physicians are not feeling good about the black box warning. Now they will have to justify why they chose a product over another one that does not have this warning. Patients are not coming in now asking for Incivik. They know that their liability has just increased dramatically if they choose it.